U.S. states sue opioid-maker Indivior over alleged anticompetitive practices

WASHINGTON (Reuters) - Thirty-five U.S. states and the District of Columbia filed a lawsuit on Thursday against opioid drug maker Indivior alleging it tried to keep generic versions of a drug off the market. British-based Indivior, which was spun off from Reckitt Benckiser in 2014, is the maker of Suboxone, a drug used to treat patients addicted to heroin and other painkillers. The lawsuit by the states alleged that Indivior took steps to get patients to switch to a dissolvable oral strip version of Suboxone. (Reporting by Sarah N. Lynch; Editing by Peter Cooney)